Targeting Mitochondria through the Use of Mitocans as Emerging Anticancer Agents

被引:8
|
作者
Macasoi, Ioana [1 ]
Mioc, Alexandra [1 ]
Mioc, Marius [1 ]
Racoviceanu, Roxana [1 ]
Soica, Irina [2 ]
Cheveresan, Adelina [3 ]
Dehelean, Cristina [1 ]
Dumitrascu, Victor [3 ]
机构
[1] Victor Babes Univ Med & Pharm, Fac Pharm, 2 Eftimie Murgu, Timisoara 300041, Romania
[2] Earlscliffe Sixth Form, 29 Shorncliffe Rd, Folkestone CT20 2NB, England
[3] Victor Babes Univ Med & Pharm, Fac Med, 2 Eftimie Murgu, Timisoara 300041, Romania
关键词
Mithocondria; cancer; mitocans; electron transport chain; hexokinase; pyruvate dehydrogenase kinase; lactate dehydrogenase; Bcl-2; PERMEABILITY TRANSITION PORE; CYTOCHROME-C RELEASE; SMALL-MOLECULE INHIBITOR; SQUAMOUS-CELL CARCINOMA; CANCER-ASSOCIATED FIBROBLASTS; ATP SYNTHASE INHIBITOR; VITAMIN-E SUCCINATE; COMPLEX-I ACTIVITY; BETULINIC ACID; RESPIRATORY-CHAIN;
D O I
10.2174/0929867326666190712150638
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mitochondria are key players with a multi-functional role in many vital cellular processes, such as energy metabolism, redox regulation, calcium homeostasis, Reactive Oxygen Species (ROS) as well as in cell signaling, survival and apoptosis. These functions are mainly regulated through important enzyme signaling cascades, which if altered may influence the outcome of cell viability and apoptosis. Therefore some of the key enzymes that are vital for these signaling pathways are emerging as important targets for new anticancer agent development. Mitocans are compounds aimed at targeting mitochondria in cancer cells by altering mitochondrial functions thus causing cell growth inhibition or apoptosis. This review summarizes the till present known classes of mitocans, their mechanism of action and potential therapeutic use in different forms of cancer.
引用
收藏
页码:5730 / 5757
页数:28
相关论文
共 50 条
  • [41] Mitochondria Determine the Efficacy of Anticancer Agents that Interact with DNA but Not the Cytoskeleton
    Hara, Kenjirou
    Kasahara, Emiko
    Takahashi, Nozomi
    Konishi, Masami
    Inoue, June
    Jikumaru, Mika
    Kubo, Shuji
    Okamura, Haruki
    Sato, Eisuke
    Inoue, Masayasu
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 337 (03): : 838 - 845
  • [42] IMPROVED BRAIN DELIVERY OF ANTIVIRAL AGENTS THROUGH THE USE OF REDOX TARGETING
    BREWSTER, ME
    BODOR, N
    ADVANCED DRUG DELIVERY REVIEWS, 1994, 14 (2-3) : 177 - 197
  • [43] Improved brain delivery of antiviral agents through the use of redox targeting
    Brewster, M.E., 1600, Publ by Elsevier Science Publishers B.V., Amsterdam, Netherlands (14): : 2 - 3
  • [44] Recent advances in mitochondria-targeting theranostic agents
    Qian, Kun
    Gao, Shu
    Jiang, Zhaoning
    Ding, Qihang
    Cheng, Zhen
    EXPLORATION, 2024, 4 (04):
  • [45] Gelation of the genome by topoisomerase II targeting anticancer agents
    Kim, Yun Soo
    Kundukad, Binu
    Allahverdi, Abdollah
    Nordenskoeld, Lars
    Doyle, Patrick S.
    van der Maarel, Johan R. C.
    SOFT MATTER, 2013, 9 (05) : 1656 - 1663
  • [46] Targeting apoptotic machinery as approach for anticancer therapy: Smac mimetics as anticancer agents
    Elsayed, Nevine M. Y.
    Abou El Ella, Dalal A.
    Serya, Rabah A. T.
    Abouzid, Khaled A. M.
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 1 (01) : 16 - 21
  • [47] Effective Agents Targeting the Mitochondria and Apoptosis to Protect the Heart
    Abdelwahid, Eltyeb
    Stulpinas, Aurimas
    Kalvelyte, Audrone
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (08) : 1153 - 1166
  • [48] Structural Perspective of Benzophenones Targeting Tubulin as Anticancer Agents
    Chourasia, Prerna
    Asati, Vivek
    Agarwal, Shivangi
    Kashaw, Varsha
    Das, Ratnesh
    Kashaw, Sushil Kumar
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2023, 23 (01) : 33 - 52
  • [49] Research of novel anticancer agents targeting arginase inhibition
    Thanh-Nhat Pham
    Liagre, Bertrand
    Girard-Thernier, Corine
    Demougeot, Celine
    DRUG DISCOVERY TODAY, 2018, 23 (04) : 871 - 878
  • [50] Development of anticancer agents targeting the Wnt/β-catenin signaling
    Zhang, Xiangqian
    Hao, Jijun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (08): : 2344 - 2360